Published in Antimicrob Agents Chemother on August 01, 1997
Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev (1999) 5.51
Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob Agents Chemother (1998) 4.95
Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother (2002) 4.52
Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Antimicrob Agents Chemother (2002) 3.40
Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. Antimicrob Agents Chemother (2000) 2.13
In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species. Eur J Clin Microbiol Infect Dis (1998) 1.71
In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates. Antimicrob Agents Chemother (1998) 1.69
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother (1999) 1.63
Evaluation of voriconazole pharmacodynamics using time-kill methodology. Antimicrob Agents Chemother (2000) 1.24
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob Agents Chemother (2002) 1.09
Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors. Antimicrob Agents Chemother (2005) 0.98
Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy. Antimicrob Agents Chemother (2006) 0.85
Growth inhibition and ultrastructural alterations induced by Delta24(25)-sterol methyltransferase inhibitors in Candida spp. isolates, including non-albicans organisms. BMC Microbiol (2009) 0.83
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis. PLoS One (2014) 0.82
Serum voriconazole levels following administration via percutaneous jejunostomy tube. Antimicrob Agents Chemother (2003) 0.79
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis. Ann Clin Microbiol Antimicrob (2011) 0.78
Effects of antineoplastic agents on growth, morphology and metabolism of Torulopsis glabrata. Mycopathologia (1986) 1.77
Antimycotic effects of octenidine and pirtenidine. J Antimicrob Chemother (1990) 1.74
Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest (1990) 2.86
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards. Antimicrob Agents Chemother (2001) 2.68
Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest (2001) 1.96
Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int (1996) 1.81
Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology (1992) 1.79
Selective activation of sar promoters with the use of green fluorescent protein transcriptional fusions as the detection system in the rabbit endocarditis model. Infect Immun (1998) 1.72
New targets and delivery systems for antifungal therapy. Med Mycol (2000) 1.65
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother (2011) 1.59
Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest (1994) 1.53
Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole. J Clin Microbiol (1996) 1.51
Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res (2005) 1.50
Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa. Infect Immun (1991) 1.46
A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob Agents Chemother (1997) 1.41
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole. J Clin Microbiol (2005) 1.41
Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J Med Vet Mycol (1986) 1.38
Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int (2001) 1.32
Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa. Infect Immun (1990) 1.32
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J Clin Microbiol (2012) 1.27
The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein. Infect Immun (1997) 1.27
Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage. Antimicrob Agents Chemother (1995) 1.24
HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion. Mod Pathol (1988) 1.20
In vivo production of leukotriene B4 and leukotriene C4 in rabbit colitis. Relationship to inflammation. Gastroenterology (1987) 1.19
The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpoints. J Oral Pathol Med (2009) 1.18
Pathogenic effects of monocytopenia, granulocytopenia and dexamethasone on the course of experimental Pseudomonas aeruginosa endocarditis in rabbits. Chemotherapy (1989) 1.16
12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy. Kidney Int (2001) 1.12
Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol (1997) 1.11
Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds. J Clin Microbiol (2007) 1.11
Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins. J Clin Invest (1990) 1.07
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients. Diagn Microbiol Infect Dis (1998) 1.05
Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa. Infect Immun (1992) 1.05
Successful isavuconazole salvage therapy in a patient with invasive mucormycosis. Infection (2013) 1.04
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model. J Chemother (1999) 1.02
Oxygen-dependent differences in exopolysaccharide production and aminoglycoside inhibitory-bactericidal interactions with Pseudomonas aeruginosa--implications for endocarditis. J Antimicrob Chemother (1989) 0.99
Regulation of eicosanoid production in rabbit colon by interleukin-1. Gastroenterology (1989) 0.99
Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol (1995) 0.98
Effects of voriconazole on Candida glabrata in vitro. J Antimicrob Chemother (1999) 0.96
Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy. Kidney Int (2001) 0.94
Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. Kidney Int (2000) 0.94
Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation (1997) 0.93
Early increased renal procollagen alpha 1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int (1992) 0.93
Chemotactic peptide-induced acute colitis in rabbits. Gastroenterology (1990) 0.93
Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med (1989) 0.92
Intravegetation antimicrobial distribution in aortic endocarditis analyzed by computer-generated model. Implications for treatment. Chest (1990) 0.89
Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) (2014) 0.89
Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program. Bone Marrow Transplant (2010) 0.88
Glucose and diabetes: effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton. Kidney Int (2006) 0.88
In vitro activity of amphotericin B against Aspergillus terreus isolates from different countries and regions. J Chemother (2008) 0.88
Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis (1998) 0.86
Up-regulation of transforming growth factor alpha binding sites in experimental rabbit colitis. Gastroenterology (1995) 0.86
Splenic immune deposits in bacterial endocarditis. Clin Immunol Immunopathol (1986) 0.85
Calcitonin gene-related peptide and substance P decrease in the rabbit colon during colitis. A time study. Gastroenterology (1991) 0.84
The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells. J Chemother (1998) 0.84
A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study. J Chemother (2000) 0.84
Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol (1995) 0.84
Cystosarcoma phyllodes metastatic to the mandible. J Surg Oncol (1988) 0.83
Effects of 16,16-dimethyl prostaglandin E2 and indomethacin on leukotriene B4 and inflammation in rabbit colitis. Prostaglandins (1988) 0.83
Ureteritis and cholecystitis: two unusual manifestations of cytomegalovirus disease in renal transplant recipients. Transplantation (1997) 0.82
Overview of the oral HIV/AIDS Research Alliance Program. Adv Dent Res (2011) 0.81
Recurrent and de novo diabetic nephropathy in renal allografts. Transplantation (2003) 0.80
Molecular mechanisms of virulence in fungus-host interactions for Aspergillus fumigatus and Candida albicans. Med Mycol (1998) 0.80
Anti-proliferative and apoptotic activities of constituents of chloroform extract of Juglans regia leaves. Cell Prolif (2014) 0.79
Differential response of glomerular epithelial and mesangial cells after subtotal nephrectomy. Kidney Int (1998) 0.79
Clinical utility of kidney biopsies in the diagnosis and management of renal disease. Am J Nephrol (1989) 0.79
Immunohistochemical distribution of renal prostaglandin endoperoxide synthase and prostacyclin synthase: diminished endoperoxide synthase in the hepatorenal syndrome. Hepatology (1987) 0.79
Mode of action of the antimicrobial compound 5-bromo-5-nitro-1,3-dioxane (bronidox). Folia Microbiol (Praha) (1986) 0.78
Recurrent Henoch-Schönlein purpura following renal transplantation. Am J Kidney Dis (1987) 0.77
Neuropeptides and inflammatory bowel disease. Z Gastroenterol Verh (1991) 0.77
Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous Fungi. J Clin Microbiol (2011) 0.76
Anti-inflammatory effects of CGP 47969A, a novel inhibitor of proinflammatory cytokine synthesis, in rabbit immune colitis. Gastroenterology (1995) 0.76
TGF-beta in renal allograft rejection. Miner Electrolyte Metab (1998) 0.76
Acquired cystic disease in chronically rejected renal transplants. J Am Soc Nephrol (1992) 0.76
Chlorambucil-induced acute hepatic failure in a patient with membranous nephropathy. Am J Kidney Dis (2000) 0.75
The meaning of microalbuminuria in type 1 diabetes: the need for a new paradigm. Curr Diab Rep (2001) 0.75
Laminin B1 is preferentially expressed in the cortex of rat kidney and is not affected by cyclosporine administration. J Lab Clin Med (1992) 0.75
Proteinuria in patients with arterial/arteriolar nephrosclerosis. Clin Nephrol (2002) 0.75
Corticomedullary procollagen alpha1(IV) mRNA levels and localization after subtotal nephrectomy. Miner Electrolyte Metab (1998) 0.75
Evaluation of fine-needle aspiration biopsy in the diagnosis of renal transplant dysfunction. Am J Kidney Dis (1991) 0.75
Frozen-section analysis of allograft renal biopsy specimens. Reliable histopathologic data for rapid decision making. Arch Pathol Lab Med (1991) 0.75
TTP-Like syndrome in a 44-year-old woman with SLE and nephritis. Am J Kidney Dis (1999) 0.75
The renal response to infection. Adv Exp Med Biol (1989) 0.75
Renal cholesterol granulomas: identification and morphological pattern of development. Histopathology (1985) 0.75
Identification of tubular cell nephron segment origin in renal fine-needle aspirates. Mod Pathol (1993) 0.75
The effect of transfection of antisense cDNA for procollagen alpha 1 (IV) on stimulated proliferation in rat glomerular endothelial cells. J Am Soc Nephrol (1997) 0.75
New approaches to Candida and oral mycotic infections: Workshop 2A. Adv Dent Res (2011) 0.75
In vivo production of leukotrienes in experimental colitis. Adv Prostaglandin Thromboxane Leukot Res (1987) 0.75
Interleukin-12 mRNA levels in renal allograft fine-needle aspirates do not correlate with acute transplant rejection. Transplantation (1995) 0.75
Growth of Candida albicans in dexamethasone-supplemented media. Sabouraudia (1985) 0.75